Product Information
LANSOPRAZOLE DR 30 MG CAPSULE is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.1067 per EA under NDC 31722057105. Its NADAC has been published 256 times since Aug 4, 2021.
Strength
30 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722057105
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LANSOPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA203083On Market Since
5/18/2020
Pharmacological Classes
Price Statistics
The NADAC for LANSOPRAZOLE DR 30 MG CAPSULE has been published 256 times since Aug 4, 2021, and over the history we have for it it has declined 32.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1067 per EA |
|---|---|
| All-time high | $0.1646 (Nov 10, 2021) |
| All-time low | $0.0754 (Nov 20, 2024) |
| 52-week high | $0.1104 |
| 52-week low | $0.1049 |
| Median price | $0.1094 |
| Average price | $0.1125 |
| Largest weekly change | -28.6% (Nov 20, 2024) |
| Weeks tracked | 256 |
| Tracking since | Aug 4, 2021 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LANSOPRAZOLE DR 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LANSOPRAZOLE DR 30 MG CAPSULE, manufactured by Camber Pharmaceuticals Inc., is $0.1067 per EA (NDC 31722057105), effective Jun 24, 2026.
How has the price of LANSOPRAZOLE DR 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LANSOPRAZOLE DR 30 MG CAPSULE has declined 32.0%. It has been tracked across 256 weekly CMS publications since Aug 4, 2021.
What are the highest and lowest recorded NADAC prices for LANSOPRAZOLE DR 30 MG CAPSULE?
Since Aug 4, 2021, the NADAC for LANSOPRAZOLE DR 30 MG CAPSULE has ranged from a low of $0.0754 (Nov 20, 2024) to a high of $0.1646 (Nov 10, 2021), with a median of $0.1094 per EA.
Are there cheaper alternatives to LANSOPRAZOLE DR 30 MG CAPSULE?
9 NADAC-published products share the same active ingredient, strength, and dosage form as LANSOPRAZOLE DR 30 MG CAPSULE, but none are currently priced below it.
Who manufactures LANSOPRAZOLE DR 30 MG CAPSULE?
LANSOPRAZOLE DR 30 MG CAPSULE (NDC 31722057105) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification